Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His second guest is Barbara Muckermann, CEO of Kempinski Hotels.
Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His first guest is Orient Express Group CEO and Chief Strategy Officer at Accor, Gilda Perez-Alvarado.
In this episode of the HealthTech CEO series, Venari Partners Senior Consultant Cristian Owen speaks with Jens Noerterhaeuser, CEO & Co-founder of Kranus Health
‘One of the things I’ve learned is you’re only as good as your team’.
Michael Ferguson joined Abivax as Chief Commercial Officer earlier this year, since then they’ve IPO’d on Nasdaq (largest French Biotech IPO ever - $212m) and Michael has been building and shaping the commercial strategy and team. We discuss all this and more in the next episode of The Venari Podcast – have a listen!
Mohamed Issa knows all about what is needed for successful life sciences launches. Before his current role as SVP of Immunology at Janssen, he held varied positions – including juggling the foundation and successful exit of Noor Pharmaceuticals at the same time as his previous day job – making him more than qualified to discuss launches both at startup and Big Pharma level.
Joe Knight caught up with Mohamed to gear his thoughts on leadership, team building, and the decisions that made him the executive he is today!
‘I think an appreciation for translational research has really started to emerge over the past few years.’ Dr Chris Winrow has had an excellent vantage point from which to observe how approaches to translational research have changed in recent years. An expert in neurodegenerative disease, with over 20 years’ experience in pharma and biotech in a variety of research, translational, and clinical roles, he joined Lucy Therapeutics as CSO in March 2023. Paula Doust Alba, our CNS & Rare Disease Consultant, welcomed Chris to an episode of the Venari Podcast’s R&D Hiring Strategy series to discuss his career, his thoughts on team building, what he looks for in new hires, and the future of translational research.
'Serendipity and interests combined' - talking healthcare startups with Fount CEO Andrew HerrAndrew joined us on the Venari Podcast to discuss what he’s learned across his career.